Daily non-political popular news in brief.

Estrogen therapy in younger postmenopausal women linked to less plaque in arteries

New results from a substudy of the Women's Health Initiative (WHI) Estrogen-Alone Trial show that younger postmenopausal women who take estrogen-alone hormone therapy have significantly less buildup of calcium plaque in their arteries compared to their peers who did not take hormone therapy.

Read more »

Keywords: estrogen, therapy, younger, postmenopausal, women, linked, plaque, arteries, artery

« Previous | Next »

Similar news on "Estrogen therapy in younger postmenopausal women linked to less plaque in arteries":

1. New WHI data show that women aged 50-59 taking oral estrogen therapy had reduced levels
   06-20-2007 · EurekAlert!
   Wyeth Pharmaceuticals, a division of Wyeth, provides comment on the Women's Health Initiative Coronary Artery Calcium Study published today in the New England Journal of Medicine. The study found that younger menopausal women (aged 50-59) who received a standard dose of oral conjugated estrogens had significantly less coronary artery calcification at the end of the study period compared with those taking placebo.
   Similar news · Read more »
   
2. Calcium in coronary arteries may be linked to increased risk for heart disease in low-risk women
   12-10-2007 · EurekAlert!
   About 5 percent of women considered low-risk for heart disease by current classification standards have evidence of advanced coronary artery calcium and may be at increased risk for cardiovascular events, according to a report in the Dec. 10/24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
   Similar news · Read more »
   
3. Estrogen use before 65 linked to reduced risk of Alzheimer's disease
   05-02-2007 · EurekAlert!
   Women who use hormone therapy before the age of 65 could cut their risk of developing Alzheimer's disease or dementia. This possibility is raised by research that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28-May 5, 2007.
   Similar news · Read more »
   
4. Estrogen study provides new impetus for development of colon cancer drugs
   12-18-2006 · EurekAlert!
   Estrogen may hold important clues for scientists working on new therapies for colon cancer, a study by Dana-Farber Cancer Institute researchers suggests. The investigators found that postmenopausal women with colon cancer lived longer and had less likelihood of dying of the disease if they had been taking estrogen supplements within five years of their diagnosis. The researchers stress that these findings do not mean estrogen should be viewed as a treatment or preventive therapy.
   Similar news · Read more »
   
5. Decrease in breast cancer incidence linked to drop in hormone replacement
   04-18-2007 · EurekAlert!
   A special report in the April 19, 2007, edition of the New England Journal of Medicine concludes that the sharp decline in breast-cancer incidence in 2003, followed by a relative stabilization at a lower rater in 2004, is most likely related to the first report of the Women's Health Initiative and the ensuing drop in hormone-replacement therapy among postmenopausal women.
   Similar news · Read more »
   
6. Estrogen use lowered one risk factor for heart disease among some younger postmenopausal women
   06-20-2007 · EurekAlert!
   A follow-up study to the federally funded Women's Health Initiative should help allay one concern in a subset of women in their 50s who are considering taking estrogen to relieve hot flashes.
   Similar news · Read more »
   
7. Flaxseed shows potential to reduce hot flashes
   08-29-2007 · EurekAlert!
   Data from a new Mayo Clinic study suggest that dietary therapy using flaxseed can decrease hot flashes in postmenopausal women who do not take estrogen. The findings from the pilot study are published in the summer 2007 issue of the Journal of the Society for Integrative Oncology.
   Similar news · Read more »
   
8. Postmenopausal hormone therapy and coronary disease -- the truth of the matter
   06-20-2007 · EurekAlert!
   The results of WHI-CACS, now published in New England Journal of Medicine are very encouraging, since women who were randomized to the estrogen arm of the WHI had significantly smaller calcification scores than counterparts in the placebo arm. This study reaffirms that estrogen has a wide range of well-documented beneficial metabolic and vascular effects, provided that treatment is started early in menopause. Women can be reassured that estrogen therapy is cardioprotective at least until age 65.
   Similar news · Read more »
   
9. Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use
   01-15-2008 · EurekAlert!
   Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
   Similar news · Read more »
   
10. Symptoms of depression linked to early stages of artery disease
    02-05-2007 · EurekAlert!
    Depressive symptoms -- especially physical signs, such as fatigue and loss of appetite -- may be associated with thickening arteries, which may reflect an early sign of coronary artery disease, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
    Similar news · Read more »